陈飞

个人信息Personal Information

副研究员

硕士生导师

教师拼音名称:chenfei

出生日期:1990-02-11

电子邮箱:

入职时间:2020-12-24

所在单位:湘雅药学院

职务:Associate Professor

学历:博士研究生毕业

性别:男

学位:博士学位

在职信息:在职

毕业院校:德国马克斯普朗克高分子研究所

学科:药学

其他联系方式Other Contact Information

邮编 :

通讯/办公地址 :

邮箱 :

个人简介Personal Profile

一、个人简介

陈飞,副研究员,硕士生导师,湖南省优青。

2024-2025借调于国家卫健委科教司项目一处,主要参与“创新药物研发”国家科技重大专项、“生育健康及妇女儿童健康保障”国家重点研发计划的相关工作

202012月入职中南大学湘雅药学院药物化学系

2019-2020博士后工作于德国明斯特大学医学院生理病理研究所,合作导师Seraphine Wegner教授

2015-2019博士毕业于德国马普高分子研究所,师从Katharina Landfester教授

2012-2015硕士毕业于国家纳米科学中心,师从梁兴杰教授

2008-2012本科毕业于华中科技大学同济药学院

现主要从事疾病早期诊断与治疗研究,聚焦光动力、声动力抗菌及抗肿瘤创新药物开发,结合分子探针与生物材料探索诊疗新策略。目前主持湖南省自然科学基金优青项目,已主持完成国家自然科学基金青年项目、湖南省自然科学基金青年项目、湖南省教育厅优青项目等,并作为核心成员参与中德国际合作交流项目、国家自然科学基金面上项目及学科交叉研究。迄今发表SCI论文60余篇,他引1700余次,其中以第一/通讯作者在Adv. Funct. Mater.2篇)、Adv. Sci.MatterActa Pharm. Sin. B.Chem. Eng. J.BiomaterialsSmallJ. Control. ReleaseAdv. Healthc. Mater.等国际期刊发表SCI论文近30篇(1篇高被引论文、2篇自然指数期刊、9篇影响因子>10);参编外文专著1部;申请国家发明专利8项(授权5项);主持校级教改课题1项,发表教改论文2篇;获得2024年中华医学科技奖二等奖;担任ExplorationIF= 22.95)学术编辑,Nano-Micro LettersIF= 36.3)、Smart MoleculesiRadiologyBME FrontiersIF= 7.7)期刊青年编委;担任Adv. Sci.等国际学术期刊审稿人。

主讲课程:本科课程《药物化学》《生物有机化学》《药物分析实验课》;研究生课程《高等药物化学选论》

个人主页:https://www.researchgate.net/profile/Fei-Chen-106

联系方式fechen@csu.edu.cn

 

二、代表性研究论文

1.      Cheng, X.; Yin, Y.; Fang, Y.; Zhou, X.; Guo, H.; Fan, D.; Zheng, F.; Ding, J.; Chen, F.;* Zeng, W.* Breaking the Depth Barrier: Dual-Activated Radical Storm from a Natural Product-Based Nanoplatform for Spatiotemporally Controlled Deep Tumor Sonodynamic Therapy. Adv. Funct. Mater. 2025, e14995. IF= 19.0,自然指数期刊)

2.      Liu, X., Ren, Y., Fan, D., Huang, S., Ma, Y., Ding, J., Luo, Z., Chen, F.,* Zeng, W. * Shining Light on Multidrug-Resistant Bacterial Infections: Rational Design of Multifunctional Organosilver-Based AIEgen Probes as Light-Activated Theranostics for Combating Biofilms and Liver Abscesses. Adv. Funct. Mater. 2023, 33, 2304974. IF= 19.0,自然指数期刊)

3.      Fan, D.; Liu, X.; Ren, Y.; Luo, Z.; Li, Y.; Dong, J.; Wegner, S. V.; Chen, F.;*  Zeng, W. * Harnessing antimicrobial peptide-coupled photosensitizer to combat drug-resistant biofilm infections through enhanced photodynamic therapy. Acta Pharm. Sin. B. 2024, 14(4), 1759-1771IF= 14.6ESI高被引)

4.      Luo, Z.; Cheng, X.; Feng, B.; Fan, D.; Liu, X.; Xie, R.; Luo, T.; Wegner, S. V.; Ma, D.; Chen, F.,* Zeng, W. * Engineering Versatile Bacteria-Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy. Adv. Sci. 2024, 11 (33), 2400049. IF= 14.3

5.      Xie, R.; Fan, D.; Cheng, X.; Yin, Y.; Li, H.; Wegner, S. V.; Chen, F.;* Zeng, W.*Living therapeutics: Precision diagnosis and therapy with engineered bacteria. Biomaterials 2025, 321, 123342. IF= 12.9

6.      Feng, B.; Ma, Y.; Zheng, F.; Huang, X.; Feng, X.; Zhang, K.; Liu, L.; Chen, F.;* Zeng, W., * Development of near-infrared lysosomal pH-activatable fluorescent probe for real-time visualization of autophagy progression. Chem. Eng. J. 2023, 464, 142554.IF= 13.2

7.      Zheng, Y.; 1 Chen, F.;1 Frank, S.; Quispe Haro, J. J.; Wegner, S. V.* Three-Color Protein Photolithography with Green, Red, and Far-Red Light. Small 2024, 20, 2405687. IF= 12.1

8.      Yin, Y.; Cheng, X.; Xie, R.; Fan, D.; Li, H.; Zhong, S.; Wegner, S. V.; Zeng, W.*; Chen, F.* Empowering bacteria with light: Optogenetically engineered bacteria for light-controlled disease theranostics and regulation. J. Control. Release 2025, 383, 113787. IF= 11.5

9.      Chen, F., Zeng, W., and Wegner, S. V. Ultrasound-activated bacteria with thermostat controls as living therapeutics. Matter 20225, 2416–2419. (IF= 17.5)

10.   Xie, R.; Fan, D.; Fang, Y.; Zhu, T.; Li, H.; Yin, Y.; Liu, X.; Ma, Y.; Chen, F.;* Zeng, W.* Dissolving Microneedles Embedded with Photosensitizers for Targeted Eradication of Gram-Positive Bacteria in Multidrug-Resistant Biofilms in Diabetic Wound Infections. Adv. Healthc. Mater. 2025, 14 (15), 2405190. IF= 9.6

11.   Yin, Y.; Cheng, X.; Fan, D.; Fang, Y.; Li, H.; Zhou, X.; Guo, H.; Zeng, W.; Chen, F. Harnessing Membrane-Targeting Photosensitizers to Evoke Ferroptosis and Pyroptosis Dual-Modal Cell Death for Antitumor Therapy. Mol. Pharm. 2025DOI: 10.1021/acs.molpharmaceut.5c01042IF= 4.5

12.   Fan, D.; Xie, R.; Liu, X.; Li, H.; Luo, Z.; Li, Y.; Chen, F.,* Zeng, W. * A peptide-based pH-sensitive antibacterial hydrogel for healing drug-resistant biofilm-infected diabetic wounds. J. Mater. Chem. B. 2024, 12 (22), 5525-5534. IF= 6.1

13.   Zheng, F., Ma, Y., Ding, J., Huang, S., Zhang, S., Huang, X., Feng, B., Zeng, H., Chen, F., * Zeng, W. * Ratiometric and discriminative visualization of autophagic processes with a novel dual-responded lysosome-specific fluorescent probe. Biomater. Res. 2023, 27(1), 66-77.IF= 8.1

14.   Huang, X.;1 Chen, F.;1 Ma, Y.; Zheng, F.; Fang, Y.; Feng, B.; Huang, S.; Zeng, H.; Zeng, W., De novo design of a novel AIE fluorescent probe tailored to autophagy visualization via pH manipulation. Biomater. Res. 2023, 27 (1), 20-37.IF= 8.1

15.   Liu, X.; Fan, D.; Ren, Y.; Huang, S.; Ding, J.; Liu, M.; Wegner, S. V.; Hou, J.; Rong, P.; Chen, F.;* Zeng, W., * Photo-Activable Organosilver Nanosystem Facilitates Synergistic Cancer Theranostics. ACS Appl. Mater. Interfaces 2023, 15 (1), 711-722.IF= 8.5

16.   Liu, X.; Fan, D.; Feng, X.; Zheng, Y.; Wegner, S. V.; Liu, M.; Chen, F.;* Zeng, W. * (2022). Breaching Bacterial Biofilm Barriers: Efficient Combinatorial Theranostics for Multidrug-Resistant Bacterial Biofilms with a Novel Penetration-Enhanced AIEgen Probe. ACS Appl. Mater. Interfaces 14 (37), 41671-41683.IF= 8.5

17.   Chen, F.; Dong, J.; Sun, W.; Di Iorio, D.; Wegner, S. V.; Zeng, W. Editorial: Construction of smart materials for biomedical application. Front. Bioeng. Biotechnol. 2023, 11, 1278243.IF= 4.3

18.   Liu, X.; Fan, D.; Feng, X.; Zheng, Y.; Wegner, S. V.; Liu, M.; Chen, F.;* Zeng, W. * (2022). Breaching Bacterial Biofilm Barriers: Efficient Combinatorial Theranostics for Multidrug-Resistant Bacterial Biofilms with a Novel Penetration-Enhanced AIEgen Probe. ACS Appl. Mater. Interfaces 14 (37), 41671-41683.IF= 8.5

19.   Zheng, F.; Huang, X.; Ding, J. P.; Bi, A.; Wang, S.; Chen, F.; * Zeng, W., * NIR-I Dye-Based Probe: A New Window for Bimodal Tumor Theranostics. Front. Chem. 2022, 10 (1), 1-23.IF= 3.8

20.   Song, R.; Ma, Y.; Bi, A.; Feng, B.; Huang, L.; Huang, S.; Huang, X.; Yin, D.; Chen, F.; * Zeng, W., * Highly selective and sensitive detection of arsenite ions(iii) using a novel tetraphenylimidazole-based probe. Anal. Methods 2021, 13 (42), 5011-5016. IF= 2.7

21.   Chen, F.; Wegner, S. V., Photoswitchable bacteria-bacteria adhesions enable the control of multicellular bacterial communities by using blue light. ACS Synthetic Biology 2020, 9 (5), 1169–1180. IF= 3.8

22.   Chen, F.; Rachel L. Warnock, Jan Roelof Van der Meer,Wegner, S. V., Bioluminescence-Triggered Photoswitchable Bacterial Adhesions enable Higher Sensitivity and Dual-readout Bacterial Biosensors for Mercury. ACS Sensors 2020, 5 (7), 2205–2210. (IF= 8.9)

23.   Chen, F.; Ricken, J.; Xu, D.; Wegner, S. V., Bacterial Photolithography: Patterning Escherichia coli Biofilms with High Spatial Control Using Photocleavable Adhesion Molecules. Advanced Biosystems 2019, 3 (3), 1800269. IF= 3.2

24.   Chen, F.; Wegner, S. V., Implementation of Blue Light Switchable Bacterial Adhesion for Design of Biofilm. Bio-protocol, 2018, 8 (12), e2893.

25.   Chen, F.; Wegner, S. V., Blue Light Switchable Bacterial Adhesion as a Key Step toward the Design of Biofilms. ACS Synthetic Biology 2017, 6 (12), 2170-2174.IF=3.8

26.   Zhao, Y.;1 Chen, F.;1 Pan, Y.; Li, Z.; Xue, X.; Okeke, C. I.; Wang, Y.; Li, C.; Peng, L.; Wang, P. C.; Ma, X.; Liang, X. J., Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance. ACS applied materials & interfaces 2015, 7 (34), 19295-305.IF= 8.5

27.   Chen, F.; Zhao, Y.; Pan, Y.; Xue, X.; Zhang, X.; Kumar, A.; Liang, X. J., Synergistically Enhanced Therapeutic Effect of a Carrier-Free HCPT/DOX Nanodrug on Breast Cancer Cells through Improved Cellular Drug Accumulation. Molecular pharmaceutics 2015, 12 (7), 2237-44.IF= 4.5

28.   Kumar, A.;1 Chen, F.;1 Mozhi, A.; Zhang, X.; Zhao, Y.; Xue, X.; Hao, Y.; Zhang, X.; Wang, P. C.; Liang, X. J., Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale 2013, 5 (18), 8307-8325.IF= 8.0

 

三、专利

1.     陈飞; 谢如燕; 曾文彬; 范多阳; 李昊翰 ; 一种光动力靶向抗菌微针贴片及其制备方法和应用, 2025-3-5, 中国, 202510256204.X

2.     曾文彬; 刘美慧; 刘小辉; 陈飞; 李石; 谢成昆; 刘祖源 ; 芳基连二咪唑类化合物、制备方法及其医药用途, 2024-7-16, 中国, 202210877081 .8 (已授权)

3.     曾文彬; 范多阳; 陈飞; 刘小辉; 董界; 罗子恒; 李艳冰 ; 一种新型多肽偶联药物化合物及其制备方法与应用, 2023-12-12, 中国, 202311701040.4

4.     曾文彬; 刘小辉; 陈飞; 董界; 范多阳; 罗子恒 ; 一种光激活肿瘤化学光动力学治疗的诊疗一体化纳米材料及其制备方法和应用, 2022-12-22, 中国, 202211654902.8

5.     梁兴杰; 陈飞; 赵元元 ; 一种多药自聚复合纳米粒子、其制备方法和应用, 2016-09-07, 中国, 201310533322.8(已授权)

6.     梁兴杰; 赵元元; 陈飞; 马晓; 李盛亮; 薛向东; 柳娟; 金叔斌; 李鸿基; 张吉梅; 王义峰; 甘雅玲; 姜永刚 ; 羟基喜树碱纳米脂束制剂及其制备方法, 2016-1-20, 中国, 201410016965.X (已授权)

7.     梁兴杰; 赵元元; 柳娟; 李盛亮; 薛向东; 陈飞; 金叔宾; 张吉梅; 李鸿基; 甘雅玲; 姜永刚 ; 一种伊立替康纳米脂束制剂及其制备方法, 2016-6-29, 中国, 201410014128.3 (已授权)

8.     梁兴杰; 李婵; 张春秋; 陈飞; 金叔宾; 王浩; 吴雁; 杨蓉 ; 一种盐酸伊立替康纳米脂束制剂及其制备方法, 2015-11-4, 中国, 201410344489.4(已授权)


  • 教育经历Education Background
  • 工作经历Work Experience
  • 研究方向Research Focus
  • 社会兼职Social Affiliations